A Global Prospective Observational Study of Women With Fabry Disease and Their Infants During Pregnancy and Breastfeeding
NCT04252066
·
clinicaltrials.gov ↗
RECRUITING
Status
20
Enrollment
INDUSTRY
Sponsor class
Conditions
Fabry Disease
Interventions
DRUG:
migalastat
Sponsor
Amicus Therapeutics